Title (COG ALTE03N1) Key Adverse Events After Childhood Cancer
Principal Investigator Martin Brecher, MD
Study Number 51505
Summary This is a non-therapeutic questionnaire to identify key adverse events developing in survivors of childhood cancers.
- Diagnosis of a primary cancer at the age 21 or younger, irrespective of current age
- No prior history of allogeneic (non-autologous) hematopoietic cell transplant
- Development of one of the following key adverse events; Congestive heart failure (CHF); Myocardial infarction (MI), Ischemic stroke (IS) Avascular necrosis (AVN); Subsequent malignant neoplasm (SMN).
- Informed consent
- In active follow-up by a COG institution.